| Original language | English |
|---|---|
| Patent number | GB2014006473 |
| IPC | HGF Ltd |
| Priority date | 21/01/15 |
| Filing date | 10/04/14 |
| Publication status | Published - 2015 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Research output
- 5 Patent
-
Use of Phytocannabinoids in the treatment of ovarian carcinoma.
Javid, F. (Inventor), 2018, IPC No. HGF Ltd, Patent No. US14/899613, 19 Jun 2014, Priority date 16 Oct 2016, Priority No. US10098867Research output: Patent
-
The use of phytocannabinoids in the treatment of ovarian carcinoma
Javid, F. (Inventor), 2017, IPC No. HGF Ltd, Patent No. GB2014006473, 10 Apr 2014, Priority date 8 Feb 2017, Priority No. GB2516335BResearch output: Patent
-
The use of phytocannabinoids in the treatment of ovarian carcinoma
Javid, F. (Inventor), 2016, IPC No. HGF Ltd, Patent No. EP2014732614, 19 Jun 2014, Priority date 27 Apr 2016, Priority No. EP3010498A1Research output: Patent
-
The use of phytocannabinoids in the treatment of ovarian carcinoma
Javid, F. (Inventor), 2014, IPC No. HGF Ltd, Patent No. GB2013010910, 19 Jun 2013, Priority date 24 Dec 2014, Priority No. GB2515312AResearch output: Patent
-
The use of phytocannabinoids in the treatment of ovarian carcinoma
Javid, F. (Inventor), 2014, Patent No. PCT/GB2014/051889, 19 Jun 2014, Priority date 24 Dec 2014, Priority No. WO2014202990A1Research output: Patent
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver